Finance

Lists
AHR:NYSE
American Healthcare REIT Inc
$55.27
-0.84%
(-0.47) 1D
Sep 4, 11:37:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHR...
Open
$55.16
High
$56.00
Low
$55.15
Mkt. cap
12.87B
Avg. vol.
2.82M
Volume
353.74K
Dividend
1.81%
Quarterly dividend
$0.25
Ex-dividend date
Jun 30, 2026
P/E ratio
81.99
52-wk high
$58.70
52-wk low
$40.00
EPS
$0.67
Shares outstanding
217.60M
No. of employees
121
Open
$55.16
High
$56.00
Low
$55.15
Mkt. cap
12.87B
Avg. vol.
2.82M
Volume
353.74K
Dividend
1.81%
Quarterly dividend
$0.25
Ex-dividend date
Jun 30, 2026
P/E ratio
81.99
52-wk high
$58.70
52-wk low
$40.00
EPS
$0.67
Shares outstanding
217.60M
No. of employees
121
News stories
From web sources and news partners
About American Healthcare REIT Inc
CEO-
Employees121
Founded2006
HeadquartersIrvine, California, United States
SectorReal estate investment trust
Websiteamericanhealthcarereit.com
Analyst ratings
Based on 13 analysts giving stock ratings to AHR in the past 3 months
Strong buy
Buy
13
Hold
0
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for AHR in the last 3 months.
Highest
Current $55.27
$71.00 (+28.46%)
Average
$64.00 (+15.80%)
Lowest
$55.00 (-0.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Nicholas Yulico
Scotiabank
Buy
Maintained
$62.00
+12.2%
09/02/2026
Richard Hightower
Barclays
Buy
Maintained
$66.00
+19.4%
08/31/2026
Michael Goldsmith
UBS
Buy
Reiterated
$63.00
+14%
08/21/2026
Austin Wurschmidt
KeyBanc
Buy
Reiterated
$68.00
+23%
08/19/2026
Farrell Granath
Bank of America Securities
Buy
Reiterated
$71.00
+28.5%
08/17/2026
Ronald Kamdem
Morgan Stanley
Buy
Reiterated
$55.00
-0.5%
08/17/2026
Michael Carroll
RBC Capital
Buy
Maintained
$61.00
+10.4%
08/14/2026
Michael Lewis
Truist Financial
Buy
Reiterated
$61.00
+10.4%
08/14/2026
Nicholas Joseph
Citi
Buy
Maintained
$65.00
+17.6%
08/13/2026
Barry Oxford
Colliers Securities
Buy
Maintained
$65.00
+17.6%
08/07/2026
Aaron Hecht
Citizens JMP
Buy
Maintained
$65.00
+17.6%
07/27/2026
Rob Simone
Compass Point
Buy
Initiated
$70.00
+26.7%
07/21/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
$60.00
+8.6%
07/13/2026
Seth Bergey
Citi
Buy
Upgraded
$55.00
-0.5%
06/23/2026
Last report
Aug 7, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.15 / $0.14
+11.48%beat
Revenue / Est. (USD)
675.14M / 669.25M
+0.88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
573.40M
604.74M
651.57M
675.14M
Cost of goods sold
467.12M
492.50M
525.27M
537.01M
Cost of revenue
467.12M
492.50M
525.27M
537.01M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.11M
16.53M
17.60M
19.89M
Operating expense
63.29M
71.85M
84.67M
92.02M
Total operating expenses
530.41M
564.35M
609.94M
629.03M
Operating income
42.99M
40.38M
41.63M
46.12M
Other non operating income
2.42M
375.00K
3.86M
2.27M
EBT including unusual items
35.55M
8.52M
23.49M
30.98M
EBT excluding unusual items
24.04M
20.95M
25.88M
29.84M
Income tax expense
-21.09M
-2.42M
-525.00K
-3.00K
Effective tax rate
-59.34%
-28.33%
-2.24%
-0.01%
Other operating expenses
-
-
-
-
Net income
55.93M
10.78M
23.71M
30.61M
Net profit margin
9.75%
1.78%
3.64%
4.53%
Earnings per share
0.27
0.14
0.14
0.15
Interest and investment income
-
-
-
-
Interest expense
-20.39M
-19.81M
-18.80M
-18.63M
Net interest expenses
-20.39M
-19.81M
-18.80M
-18.63M
Depreciation and amortization charges
49.18M
55.32M
67.06M
72.12M
EBITDA
101.02M
105.55M
116.41M
125.87M
Gain or loss from assets sale
-691.00K
621.00K
-
-5.65M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps